Antiverse: Funding, Investors & Team (Sep 2026)
Antiverse is a Welsh techbio company specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to change lives. Headquartered in Cardiff, UK and with offices in Boston, MA, we combine state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics.
Antiverse has raised $15.8M across 3 funding rounds on record, the most recent a Series A of $9.3M announced in Mar 2026.
That round is above the $5.8M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Antiverse Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Antiverse Funding Rounds
Antiverse raised $1.9M in a Seed announced in Mar 2021.
3.6 years later, a Seed of $4.6M was announced in Oct 2024.
1.4 years later, a Series A of $9.3M was announced in Mar 2026.
Antiverse Founders and Leadership Team
Contact details for the Antiverse team: 2 of 2 have an email address on file.
Start 14-day free trial →Antiverse Funding Compared to Other Artificial Intelligence Startups
Antiverse's latest round of $9.3M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Antiverse in Artificial Intelligence and Cardiff
Companies Similar to Antiverse
The largest GPU Cloud purpose built for AI. Instantly deploy thousands of NVIDIA H100s and A100s on demand,…
Stability AI is developing open AI resources that enable us to maximize our capabilities. We create and…
Callosum provides data analytics, artificial intelligence, and digital engineering services for data…
Medly AI is an advanced tutor that is able to support students in multiple languages through the use of…
Mindgard is an AI security company that assists businesses in safeguarding their AI models against cyber…
Edgify is a developer of a predictive personalization technology used to analyze a user's photos on their…
The AI agents provided by Finster AI possess the ability to comprehend, evaluate, and incorporate various…
Malted AI is a company that designs a low-code platform that allows businesses to create and launch…
OLIX designs and manufactures optical processors that use light-based circuits to accelerate artificial…
Qureight is a company specializing in imaging analytics, with a goal of enhancing its analytical platform to…
Greyparrot is the leading AI waste analytics platform for the circular economy. We are on a mission to…
Founded by Dr. Sam Tukra and Callum Adamson (who have been working together since 2019) in 2023 to solve the…
Antiverse Funding FAQs
What does Antiverse do?
Antiverse is a Welsh techbio company specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to change lives. Headquartered in Cardiff, UK and with offices in Boston, MA, we combine state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics.
How much funding has Antiverse raised?
Antiverse has raised $15.8M across 3 rounds on record. The most recent is a Series A of $9.3M announced in Mar 2026.
When did Antiverse last raise funding?
Antiverse's most recent funding round on record is a Series A of $9.3M, announced in Mar 2026.
Who founded Antiverse?
FundedIQ lists Ben Holland (Founder) at Antiverse.
Who is the CEO of Antiverse?
Murat Tunaboylu is listed as CEO at Antiverse.
Where is Antiverse headquartered?
Antiverse is based in Cardiff, United Kingdom.
How many employees does Antiverse have?
Antiverse is in the 11-50 employee band.
How does Antiverse's funding compare to other Artificial Intelligence startups?
Antiverse's latest round of $9.3M is above the $5.8M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Antiverse Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Antiverse is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.